श्रीरंग बारणेंना खासदार बनवण्यासाठी सुधाकर भाऊ घारेंनी लावली ताकत : कर्जत- खालापूर मतदारसंघात आढावा बैठकांचे सत्र सुरु-Dr L H Hiranandani Hospital marks 50 Bone Marrow Transplants-Bank of Baroda ropes in Kunaal Roy Kapur for PehchaanCon 3.0 campaign to spread awareness on new-age financial frauds-आजच्या युगातील आर्थिक फसवणुकीबद्दल जागरुकता निर्माण करण्यासाठी बँक ऑफ बडोदाने पेहचानकॉन 3.0 कॅम्पेनसाठी केली कुणाल रॉय कपूरशी हातमिळवणी.-GJEPC: The Authorized Economic Operator (AEO) Status Now Extended To The Gem & Jewellery Sector-GJEPC: Plain Gold Jewellery Exports Grew by 61.72% to US$ 6792.24 million in FY 2023-24-Dabur Glucose launches ‘Energize India’ Campaign to Promote Young Athletes-The Yoga Institute Santa Cruz, Mumbai Announces Free Access to "Samattvam" Yoga OPD in Honor of Dr. Jayadeva Yogendra's Birth Anniversary on 27th April 2024-Bullet Echo India scales the Google Play Store charts; KRAFTON and ZeptoLab officially announce the launch of the game in India-ड्रोन डेस्टिनेशनने 'डेंटसू क्रिएटिव्ह पीआर'ची पीआर एजन्सी म्हणून नियुक्ती केली

Infibeam Incorporation Limited: Public Issue opens on March 21, 2016 & closes on March 23, 2016 Price Band fixed from Rs. 360 to Rs. 432 per Equity Share

Mumbai, March 15, 2016: Infibeam Incorporation Limited (the “Company” or “Issuer”) will open on Monday, March 21, 2016, a Public issue of equity shares of Face Value of Rs. 10 each (the “Equity Shares”) for cash at a Price Band from Rs. 360 to Rs. 432 per Equity Share (including a share premium) aggregating up to Rs. 4,500 million.
ib2
The Global Co-ordinator and Book Running Lead Manager (“GCBRLM”) to the Public Issue is SBI Capital Markets Limited and the Book Running Lead Manager (“BRLM”) is Elara Capital (India) Private Limited.

The Company may, in consultation with the GCBRLM and BRLM consider participation by Anchor Investors in accordance with the SEBI ICDR Regulations. Bids can be made for a minimum of 34 Equity Shares and in multiples of 34 Equity Shares thereafter. The Bid/ Issue closes on Wednesday, March 23, 2016.

Mr.Vishal Mehta MD Infibeam

Mr.Vishal Mehta MD Infibeam


The Equity Shares offered through the Issue are proposed to be listed on BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”). BSE shall be the Designated Stock Exchange. 

The Issue is being made through the Book Building Process wherein at least 75% of the Issue shall be Allotted on a proportionate basis to Qualified Institutional Buyers (“QIBs”), provided that our Company may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis.
ib1
5% of the QIB Portion (excluding the Anchor Investor Portion) shall be available for allocation on a proportionate basis to Mutual Funds only and the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Issue Price. If at least 75% of the Issue cannot be Allotted to QIBs, then the entire application money shall be refunded forthwith. Further, not more than 15% of the Issue shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not more than 10% of the Issue shall be available for allocation to Retail Individual Bidders in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended (the “SEBI Regulations”), subject to valid Bids being received at or above the Issue Price. All potential investors, other than Anchor Investors, are required to mandatorily utilise the Application Supported by Blocked Amount (“ASBA”) process providing details of their respective bank account which will be blocked by the Self Certified Syndicate Banks (“SCSBs”), to participate in this Issue.

About the Author

Sachin Murdeshwar
Sachin Murdeshwar is a Sr.Journalist and Columnist in several Mainline Newspapers and Portals.He is an ardent traveller and likes to explore destinations to the core.